Sangamo Therapeutics, Inc a genomic medicine company, today announced it has signed an evaluation and option agreement with Prevail Therapeutic a wholly owned

TauRx Pharmaceuticals Ltd., a global leader in Tau-based research in Alzheimer’s disease today announced results from a prespecified analysis of the Phase 3 LUCIDITY

Eli Lilly and Company and Versanis Bio today announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases.

Acadia Pharmaceuticals Inc. today announced that it has expanded its current licensing agreement for trofinetide with Neuren Pharmaceuticals to acquire ex-North American

KSQ Therapeutics, Inc. a clinical-stage biotechnology company developing cancer therapies using its proprietary CRISPRomics® discovery platform, announced today

Credible, a San Francisco-headquartered, AI-powered ESG Company has onboarded Ajanta Pharma Ltd, a leading global pharmaceutical company to improve its ESG

Liminal BioSciences Inc.and Structured Alpha LP a fund managed by Thomvest Asset Management Ltd., today announced that they have entered into a definitive arrangement

Bridge Biotherapeutics, a South Korean clinical-stage biotech company developing novel drugs for fibrosis, cancer and inflammation, announced that it has joined PROLIFIC, the Prognostic Lung Fibrosis Consortium, an organization devoted to boosting scientific exploration

Redwood Scientific Technologies Inc., a pioneering pharmaceutical company based in New York, is proud to announce the filing of a new patent for its cutting-edge Oral Thin Film (OTF) manufacturing system. The patent showcases Redwood's commitment to revolutionizing

Zhejiang Doer Biologics Co., Ltd. a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announced that it has entered into a license agreement with BioNTech SE.